In a move blending health education with visual awareness, over 26,000 CBSE schools across India have been instructed to ...

Adults with a mental illness experienced weight loss and glycemic benefits with use of a GLP-1 without worsening of mental ...

VYKAT XR was approved by the U.S. Food and Drug Administration (FDA) on March 26, 2025, and is now commercially available to ...

Clarity Pharmaceuticals ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with ...

The highest dividend-paying stocks in the S&P 500 right now are blue-chip stocks that yield anywhere between 6.2% and 9.3% annually. And while markets are largely flat since Jan. 1 — with a ...

Findings for matched groups of patients with obesity and diabetes taking first-generation GLP-1 RA or undergoing bariatric metabolic surgery. (HealthDay News) — Glucagon-like peptide-1 receptor ...

Published in PLOS Complex Systems, the study found that ADHD may raise obesity risk through both behavioral and biological pathways, and that this link changes depending on where someone lives. ADHD ...

The number of overweight people has nearly tripled from 929 million in 1990 to 2.6 billion today, with children facing a projected 121% increase in obesity rates ...

Queen Latifah opens up about obesity and heart health risks for public awareness campaign, Truth About Weight.

A new study has found GLP-1s may reduce the risk of developing obesity-related cancers by 41% compared to bariatric surgery — a benefit researchers believe could be tied to the drugs’ ability ...